Reseptregisteret 2013–2017 the Norwegian Prescription Database

Reseptregisteret 2013–2017 the Norwegian Prescription Database

LEGEMIDDELSTATISTIKK 2018:2 Reseptregisteret 2013–2017 Tema: Legemidler og eldre The Norwegian Prescription Database 2013–2017 Topic: Drug use in the elderly Reseptregisteret 2013–2017 Tema: Legemidler og eldre The Norwegian Prescription Database 2013–2017 Topic: Drug use in the elderly Christian Berg Hege Salvesen Blix Olaug Fenne Kari Furu Vidar Hjellvik Kari Jansdotter Husabø Irene Litleskare Marit Rønning Solveig Sakshaug Randi Selmer Anne-Johanne Søgaard Sissel Torheim Utgitt av Folkehelseinstituttet/Published by Norwegian Institute of Public Health Område for Helsedata og digitalisering Avdeling for Legemiddelstatistikk Juni 2018 Tittel/Title: Legemiddelstatistikk 2018:2 Reseptregisteret 2013–2017 / The Norwegian Prescription Database 2013–2017 Forfattere/Authors: Christian Berg, redaktør/editor Hege Salvesen Blix Olaug Fenne Kari Furu Vidar Hjellvik Kari Jansdotter Husabø Irene Litleskare Marit Rønning Solveig Sakshaug Randi Selmer Anne-Johanne Søgaard Sissel Torheim Acknowledgement: Julie D. W. Johansen (English text) Bestilling/Order: Rapporten kan lastes ned som pdf på Folkehelseinstituttets nettsider: www.fhi.no The report can be downloaded from www.fhi.no Grafisk design omslag: Fete Typer Ombrekking: Houston911 Kontaktinformasjon/Contact information: Folkehelseinstituttet/Norwegian Institute of Public Health Postboks 222 Skøyen N-0213 Oslo Tel: +47 21 07 70 00 ISSN: 1890-9647 ISBN: 978-82-8082-926-9 Sitering/Citation: Berg, C (red), Reseptregisteret 2013–2017 [The Norwegian Prescription Database 2013–2017] Legemiddelstatistikk 2018:2, Oslo, Norge: Folkehelseinstituttet, 2018. Tidligere utgaver / Previous editions: 2008: Reseptregisteret 2004–2007 / The Norwegian Prescription Database 2004–2007 2009: Legemiddelstatistikk 2009:2: Reseptregisteret 2004–2008 / The Norwegian Prescription Database 2004–2008 2010: Legemiddelstatistikk 2010:2: Reseptregisteret 2005–2009. Tema: Vanedannende legemidler / The Norwegian Prescription Database 2005–2009. Topic: Addicitiv drugs 2011: Legemiddelstatistikk 2011:2: Reseptregisteret 2006–2010 / The NorwegianPrescription Database 2006–2010 2012: Legemiddelstatistikk 2012:2: Reseptregisteret 2007–2011. Tema: Legemidler og eldre / The Norwegian Prescription Database 2007–2011. Topic: Drug use in the elderly 2013: Legemiddelstatistikk 2013:2: Reseptregisteret 2008–2012 / The Norwegian Prescription Database 2008–2012 2014: Legemiddelstatistikk 2014:2: Reseptregisteret 2009–2013 / The Norwegian Prescription Database 2009–2013 2015: Legemiddelstatistikk 2015:2: Reseptregisteret 2010–2014. Tema: Antibiotika / The Norwegian Prescription Database 2010–2014. Topic: Antibiotics 2016: Legemiddelstatistikk 2016:2: Reseptregisteret 2011–2015 / The NorwegianPrescription Database 2011–2015 2017: Legemiddelstatistikk 2017:2: Reseptregisteret 2012–2016 / The Norwegian Prescription Database 2012–2016 Innhold Forord ........................................................................................................................................................................7 1. Legemidler og eldre ................................................................................................................................................8 1.1 Legemiddelbruk hos eldre (≥ 65 år) – noen nøkkeltall .............................................................................................. 8 1.2 Bruk av legemidler mot aldersdemens .................................................................................................................... 15 1.3 Bruk av legemidler ved hjerte- og karsykdommer og antitrombotiske legemidler hos eldre .................................. 19 1.4 Bruk av legemidler mot osteoporose hos eldre ....................................................................................................... 24 1.5 Bruk av smertestillende legemidler hos eldre ........................................................................................................ 30 1.6 Bruk av sovemidler og beroligende midler hos eldre ............................................................................................. 34 1.7 Bruk av antibiotika hos eldre ................................................................................................................................... 37 2. Generelt om Reseptregisteret (NorPD) og legemiddelstatistikk ............................................................................40 2.1 Reseptregisteret ...................................................................................................................................................... 40 2.2 Nordiske reseptregistre .......................................................................................................................................... 44 2.3 Grossistbasert legemiddelstatistikk ........................................................................................................................ 44 2.4 Anatomisk Terapeutisk Kjemisk (ATC)-klassifikasjon................................................................................................ 45 2.5 Definert Døgndose (DDD) ........................................................................................................................................ 46 2.6 WHO Collaborating Centre for Drug Statistics Methodology .................................................................................. 47 3. Reseptregisteret (NorPD) 2013–2017 ....................................................................................................................48 3.1 Utvalgte nøkkeltall fra Reseptregisteret .................................................................................................................. 48 3.2 Reseptkategorier og refusjon av utgifter til legemidler ....................................................................................... 52 3.3 Beskrivelse av hovedtabellene ............................................................................................................................... 56 3.4 ATC main groups ...................................................................................................................................................... 60 3.5 ATC group A – Alimentary tract and metabolism..................................................................................................... 61 3.6 ATC group B – Blood and bloodforming organs ....................................................................................................... 72 3.7 ATC group C – Cardiovascular system ..................................................................................................................... 75 3.8 ATC group D – Dermatologicals ............................................................................................................................... 83 3.9 ATC group G – Genito urinary system and sex hormones ........................................................................................ 89 3.10 ATC group H – Systemic hormonal preparations, excl. sex hormones and insulins ............................................... 94 3.11 ATC group J – Antiinfectives for systemic use ........................................................................................................ 97 3.12 ATC group L – Antineoplastic and immunomodulating agents ............................................................................ 104 3.13 ATC group M – Musculo-skeletal system ............................................................................................................ 107 3.14 ATC group N – Nervous system ........................................................................................................................... 110 3.15 ATC group P – Antiparasitic products, insecticides and repellents ...................................................................... 120 3.16 ATC group R – Respiratory system ...................................................................................................................... 122 3.17 ATC group S – Sensory organs ............................................................................................................................. 127 3.18 ATC-group V – Various ......................................................................................................................................... 131 Noen forkortelser og definisjoner ..........................................................................................................................133 Definisjoner ...........................................................................................................................................................134 Folkemengde i Norge 2013–2017 (per 1. juli) .........................................................................................................134 Folkemengde etter alder i 2017 (per 1. juli) ............................................................................................................134 Liste over vitenskapelige publikasjoner basert på data fra Reseptregisteret per 31.12.2017 ...................................135 Legemiddelstatistikk 2018:2 • Folkehelseinstituttet 5 Contents Preface .......................................................................................................................................................................7 1. Drug use in the elderly ............................................................................................................................................8 1.1

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    144 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us